Slingshot members are tracking this event:

Lipocine (LPCN) Releases Phase 2b Results for Oral Testosterone Replacement Therapy LPCN 1111

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 26, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2b Results, Oral Testosterone Replacement Therapy, Lpcn 1111